IR2-9 Response Accepted Self-assessed

Status of Awards and Legal Rights

Recommendation

I recommend that, with reference to the status of awards: a) eligible infected and affected persons should not be required to accept the offer of an award in full and final settlement of any right to pursue legal actions related to the infection; b) any accepted scheme award should be set off against any entitlement to damages for the same subject matter; c) the availability of an award under the scheme should be a factor to which the court could have regard when determining liability for costs in any court proceedings related to the infection.

Published Evidence Summary
The following publicly available evidence relates to this recommendation:
According to Gov.uk progress updates (17 Dec 2024) and UK Parliament (2025-12-31), the government has implemented provisions within the Infected Blood Compensation Scheme regulations, enacted in August 2024, March 2025, and December 2025, which confirm that accepting a scheme award does not require claimants to waive their right to pursue legal actions. According to a Gov.uk progress update (2025-05-14), the scheme also stipulates that any accepted award will be set off against damages for the same subject matter in court, and courts may consider the scheme's availability in costs decisions. Furthermore, according to a Gov.uk progress update (17 Dec 2024), the scheme allows for reassessment and additional payments if an infected person's condition deteriorates.
How was this assessed?
Assessed by gemini-2.5-flash on 19 Mar 2026
Checked data held on this site (government responses, progress updates, independent evidence)
External sources searched: www.gov.uk, www.legislation.gov.uk, hansard.parliament.uk
Jurisdiction
UK-wide
Response
Accepted
Accepted UK Government Initial Response
17 Dec 2024

In line with recommendations 9 and 10 of the Second Interim Report, acceptance of an award does not require applicants to waive their right to pursue litigation. In defined circumstances, if an infected person's condition deteriorates after their compensation award has been assessed, they will be able to return to IBCA for reassessment to determine whether they are eligible for an additional compensation payment. A reassessment following a health deterioration will be possible at any time, regardless of the time that has passed since a person's initial assessment.

Read Full Response
Accepted UK Government Follow-up
14 May 2025

Accepting a scheme award does not require waiver of legal rights. Awards are set off against court damages for the same subject. Courts may consider scheme availability in costs decisions.

Read Full Response
Progress Timeline
Official Report
17 Dec 2024

Award status provisions implemented in scheme regulations.

Published Evidence

Published assessments of implementation progress from inspectorates, select committees, official progress reports, and other sources. Check the source type badge to see whether each assessment is independent or government self-reported.

Good Progress
15 Jan 2026
IBCA Community Update Other

As of 13 January 2026: 3,721 people asked to start claims, 3,546 begun process, 3,074 received offers totalling £2.47bn, 2,861 paid totalling £1.89bn. Third compensation regulations in force 31 December 2025.

View detailed findings

IBCA exceeded initial expectations. Three sets of regulations now in force covering infected persons, affected persons, and supplementary routes. £11.8bn committed in October 2024 Budget. Independent review found "very creditable progress."

IBCA Community Update, 15 January 2026 View Source
Good Progress
31 Dec 2025
UK Parliament legislation

Victims and Prisoners Act 2024 established IBCA. Three sets of scheme regulations in force (Aug 2024, Mar 2025, Dec 2025). First payments December 2024. £1.89bn paid to 2,861 people by January 2026.

Infected Blood Compensation Scheme Regulations 20… View Source
Reasonable Progress
28 Oct 2025
IBCA Independent Review Other

IBCA has contacted 2,215 people to begin compensation claims; 1,934 started process. £812m+ paid via Horizon Shortfall Scheme. £11.8bn committed in Autumn Budget.

View detailed findings

IBCA exceeded expectations for first cohort and established operational service with "compassionate ethos." Target: bulk of infected payments by 2027, affected by 2029. Third compensation scheme regulations came into law 31 December 2025.

IBCA CO-Sponsored Independent Review Report, Octo… View Source
Source
Report Second Interim Report 05 Apr 2023
Responsible Bodies
UK Government Primary
Recommendation age 3.0 yrs
Last formal update 14 May 2025